Scientists at the Leibniz Institute of Photonic Technology (Leibniz IPHT) have developed a new microarray-based diagnostic platform that can help close vaccination gaps and quickly detect ...
The biochip market size is calculated at USD 14.37 billion in 2025 and is expected to reach around USD 42.15 billion by 2034, ...
Q3 2025 Earnings Call Transcript November 13, 2025 Bionano Genomics, Inc. beats earnings expectations. Reported EPS is ...
Revenue Guidance -- Management reiterated full-year fiscal 2025 revenue guidance of $26 million to $30 million and set Q4 ...
Quarter Highlighted by GEO-MVA Acceleration Amid Global Mpox Emergency, Gedeptin(R) Expansion Into New Solid Tumor Programs, and Strong GEO-CM04S1 Clinical Data in Immunocompromised Patients Company ...
New York-based biotech startup Panther Life Sciences will expand its presence in Pittsburgh after completing a successful ...
Bionano Genomics, Inc. ( BNGO) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Good day, and welcome to the Bionano Third Quarter 2025 Earnings Conference Call. Today's conference is being ...
News-Medical.Net on MSN
Drinking orange juice daily may fine-tune genes tied to cardiovascular wellness
Regular orange juice consumption reprograms immune-cell gene activity linked to blood pressure, lipid metabolism, and ...
By procedure type, the preimplantation genetic testing market is divided by procedure type into preimplantation genetic ...
Seasoned global pharmaceutical executive, Mr Brent MacGregor, joins Vaxxas Board to accelerate self-administered HD-MAP vaccines for global use;SPRIM Global Investment’s Co-Founder and Managing ...
18 小时on MSN
GeoVax outlines expedited GEO-MVA clinical trial and global partnership strategy for 2025-2026
Discover key insights from GeoVax Labs’ Q3 2025 earnings call—expedited vaccine trials, partnership updates & clinical progress.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果